CIK 0001355790
- Non-accelerated filer
- Smaller reporting company
International Stem Cell CORP
Sign in to watch- Ticker
- ISCO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 204494098
- Phone
- +1 760-940-6383
- Business address
- 9745 BUSINESSPARK AVENUE, SAN DIEGO, CA, 92131
- Former names
- BTHC III INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,497
- in 1 filing
Net −$10,497. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-10-16 | Semechkin Ruslan Chief Science Officer | Option exercise · Series A Warrant (Right to Buy) | +666,667 | 1,334,334 | ||
| 2013-10-16 | Semechkin Ruslan Chief Science Officer | Option exercise · Series B Warrant (Right to Buy) | −666,667 | 1,000 | ||
| 2013-07-24 | Semechkin Andrey Chief Executive Officer | Purchase | +5,998,999 | $0.15 | $900K | 18,536,799 |
| 2013-07-24 | Semechkin Andrey Chief Executive Officer | Purchase · Series A Warrant (Right to Buy) | +5,998,999 | 5,998,999 | ||
| 2013-07-24 | Semechkin Andrey Chief Executive Officer | Purchase · Series B Warrant (4) (Right to Buy) | +5,998,999 | 5,998,999 | ||
| 2013-07-24 | Semechkin Ruslan Chief Science Officer | Purchase | +667,667 | $0.15 | $100K | 693,297 |
| 2013-07-24 | Semechkin Ruslan Chief Science Officer | Purchase · Series A Warrant (Right to Buy) | +667,667 | 667,667 | ||
| 2013-07-24 | Semechkin Ruslan Chief Science Officer | Purchase · Series B Warrant (Right to Buy) | +667,667 | 667,667 | ||
| 2013-06-20 | Don Wright Director | Grant or award | +65,000 | 292,500 | ||
| 2013-06-20 | MAIER PAUL V Director | Grant or award | +40,000 | 242,500 | ||
| 2013-06-20 | CASAMENTO CHARLES J Director | Grant or award | +40,000 | 242,500 | ||
| 2013-06-20 | BERGLUND JAMES H Director | Grant or award | +40,000 | 392,500 | ||
| 2013-04-09 | Semechkin Ruslan Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2013-04-09 | Nguyen Linh T Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2013-04-09 | Semechkin Andrey Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2013-04-09 | Craw John Simon Executive Vice President | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2013-03-12 | Semechkin Andrey Chief Executive Officer | Purchase | +500,000 | $0.20 | $100K | 12,537,800 |
| 2013-03-12 | Semechkin Andrey Chief Executive Officer | Purchase · Common Stock Warrant (Right to Buy) | +250,000 | 250,000 |
Page 15 of 15 · 298 trades